CONTENT

Destacados

HIVACAT
IrsiCaixa >> Research >> Seminars and Congresses

15th Conference on Retroviruses and Opportunistic Infections. Boston, USA

03.02.08

Publications and presentations related to the conference

  • 03/02/2008 - HIV-1 Transmission from Infected Dendritic Cells and Infection of Primary CD4+ T Lymphocytes in the Presence of Entry Inhibitors Targeting Co-receptors or gp41

    Background: Cell-to-cell transmission is one of the most efficient mechanisms of HIV spread. Dendritic cells capture HIV-1 particles and potently promote their transmission to CD4+ T cells. We have shown that contacts between HIV-producing...

    J. Este, I. Clotet, B Bosch, M. Fernandez-Figueras, R. Pena, M. Bofill, and B. Clotet

  • 03/02/2008 - Prospective Validation of Simple Biological Markers in Assessing Liver Fibrosis in HIV/HCV/co-infected Patients

    Background: The degree of liver fibrosis is determinant for prognosis of chronic hepatitis C virus (HCV) infection and for initiation of therapy. Liver biopsy is the current invasive, risky, and costly gold...

    J. Tor, C. Tural, R. Muga, I. Ojanguren, E. Barluenga, A. Sanvisens, E. Martinez, C. Rey-Joly, and B. Clotet

  • 03/02/2008 - Severe Primary Sexually Transmitted HIV Infection Due to Dual-tropic HIV-1

    Boston (MA), USA

  • 03/02/2008 - A novel HCV NS3/4A protease assay using a bacteriophage lambda based genetic screen

    S. Franco, MA. Martínez, B. Clotet

  • 03/02/2008 - Inhibitory quotient as a predictor of virological response to darunavir-based salvage regimens

    J. Moltó, J. Santos, N. Pérez-Alvarez, S. Cedeño, C. Miranda, S. Khoo, L. Else, J. Llibre, M. Valle, B.Clotet.

  • 03/02/2008 - DUET-2: week-48 results of a phase III randomized double-blind trial to evaluate the efficacy and safety of TMC125 vs placebo in 591 treatment-experienced HIV-1 infected patients

    M. Johnson, T. Campbell, B. Clotet, C. Katlama, A. Lazzarin, W. Towner, M. Peeters, J. Vingerhoets, S. Bollen, G. De Smedt on the behalf of the DUET-2 Study Group

  • 03/02/2008 - The use and response to second combination ART regimens in EuroSIDA

    A. Cozzi-Lepri, M. Cunnington, A. Lazzarin, B. Clotet, B. Knysz, P. Gargalianos, C. Katlama, A. Karlsson, A. Phillips, J. Lundgren, EuroSIDA Study Group

  • 03/02/2008 - Prospective validation of simple biological markers in assessing liver fibrosis in HIV/HCV/co-infected patients

    J. Tor, C. Tural, R. Muga, I. Ojanguren, E. Barluenga, A. Sanvisens, E. Martinez, C. Rey-Joly, B. Clotet